Piotr Z. Sobanski

Piotr Z. Sobanski

Auto-generated profile, based on publicly available information

Piotr Z. Sobanski

Palliative Care Unit and Competence Center, Spital Schwyz

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2019 in Cardiovascular Research
Verified
Journal Article
Closed access
PSPiotr Z Sobanski
Piotr Z Sobanski
BABernd Alt-Epping
Bernd Alt-Epping
DCDavid C Currow
David C Currow
SGSarah J Goodlin
Sarah J Goodlin
TGTomasz Grodzicki
Tomasz Grodzicki
PLPhilip J Larkin
Philip J Larkin
Contrary to common perception, modern palliative care (PC) is applicable to all people with an incurable disease, not only cancer. PC is appropriate at every stage of disease progression, when PC needs emerge. These needs can be of physical, emotional, social, or spiritual nature. This document encourages the use of validated assessment tools to recognize such needs and ascertain efficacy of management. PC interventions should be provided alongside cardiologic management. Treating breathlessness is more effective, when cardiologic management is supported by PC interventions. Treating other symptoms like pain or depression requires predominantly PC interventions. Advance Care Planning aims to ensure that the future treatment and care the person receives is concordant with their personal values and goals, even after losing decision-making capacity. It should include also disease specific aspects, such as modification of implantable device activity at the end of life. The Whole Person Care concept describes the inseparability of the physical, emotional, and spiritual dimensions of the human being. Addressing psychological and spiritual needs, together with medical treatment, maintains personal integrity and promotes emotional healing. Most PC concerns can be addressed by the usual care team, supported by a PC specialist if needed. During dying, the persons’ needs may change dynamically and intensive PC is often required. Following the death of a person, bereavement services benefit loved ones. The authors conclude that the inclusion of PC within the regular clinical framework for people with heart failure results in a substantial improvement in quality of life as well as comfort and dignity whilst dying.

5 January 2014 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
PSPiotr Sobanski
Piotr Sobanski
MKMalgorzata Krajnik
Malgorzata Krajnik
MSMohammed Shaqura
Mohammed Shaqura
EBElzbieta Bloch-Boguslawska
Elzbieta Bloch-Boguslawska
MSMichael Schäfer
Michael Schäfer
SMShaaban A. Mousa
Shaaban A. Mousa

29 August 2020 in European Heart Journal
Verified
Journal Article
Closed access
MSMarkus Schwerzmann
Markus Schwerzmann
EGEva Goossens
Eva Goossens
PGPastora Gallego
Pastora Gallego
AKAdrienne H Kovacs
Adrienne H Kovacs
PMPhilip Moons
Philip Moons
CTCorina Thomet
Corina Thomet
Survival prospects in adults with congenital heart disease (CHD), although improved in recent decades, still remain below expectations for the general population. Patients and their loved ones benefit from preparation for both unexpected and predictable deaths, sometimes preceded by a prolonged period of declining health. Hence, advance care planning (ACP) is an integral part of comprehensive care for adults with CHD. This position paper summarizes evidence regarding benefits of and patients’ preferences for ACP and provides practical advice regarding the implementation of ACP processes within clinical adult CHD practice. We suggest that ACP be delivered as a structured process across different stages, with content dependent upon the anticipated disease progression. We acknowledge potential barriers to initiate ACP discussions and emphasize the importance of a sensitive and situation-specific communication style. Conclusions presented in this article reflect agreed expert opinions and include both patient and provider perspectives.

1 January 2010 in Pharmacological Reports
Verified
Journal Article
Closed access
MKMałgorzata Krajnik
Małgorzata Krajnik
MSMichael Schäfer
Michael Schäfer
PSPiotr Sobański
Piotr Sobański
JKJanusz Kowalewski
Janusz Kowalewski
EBElżbieta Bloch-Bogusławska
Elżbieta Bloch-Bogusławska
SMShaaban A. Mousa
Shaaban A. Mousa

5 February 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
PSPiotr Z. Sobanski
Piotr Z. Sobanski
MKMalgorzata Krajnik
Malgorzata Krajnik
SGSarah J. Goodlin
Sarah J. Goodlin
The distribution of individual heart disease differs among women and men and, parallel to this, among particular age groups. Women are usually affected by cardiovascular disease at an older age than men, and as the prevalence of comorbidities (like diabetes or chronic pain syndromes) grows with age, women suffer from a higher number of symptoms (such as pain and breathlessness) than men. Women live longer, and after a husband or partner's death, they suffer from a stronger sense of loneliness, are more dependent on institutionalized care and have more unaddressed needs than men. Heart failure (HF) is a common end-stage pathway of many cardiovascular diseases and causes substantial symptom burden and suffering despite optimal cardiologic treatment. Modern, personalized medicine makes every effort, including close cooperation between disciplines, to alleviate them as efficiently as possible. Palliative Care (PC) interventions include symptom management, psychosocial and spiritual support. In complex situations they are provided by a specialized multiprofessional team, but usually the application of PC principles by the healthcare team responsible for the person is sufficient. PC should be involved in usual care to improve the quality of life of patients and their relatives as soon as appropriate needs emerge. Even at less advanced stages of disease, PC is an additional layer of support added to disease modifying management, not only at the end-of-life. The relatively scarce data suggest sex-specific differences in symptom pathophysiology, distribution and the requisite management needed for their successful alleviation. This paper summarizes the sex-related differences in PC needs and in the wide range of interventions (from medical treatment to spiritual support) that can be considered to optimally address them.

11 December 2017 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
PJPiotr Janowiak
Piotr Janowiak
MKMałgorzata Krajnik
Małgorzata Krajnik
ZPZygmunt Podolec
Zygmunt Podolec
TBTomasz Bandurski
Tomasz Bandurski
IDIwona Damps-Konstanska
Iwona Damps-Konstanska
EJEwa Jassem
Ewa Jassem
Systemic morphine has evidence to support its use for reducing breathlessness in patients with severe chronic obstructive pulmonary disease (COPD). The effectiveness of the nebulized route, however, has not yet been confirmed. Recent studies have shown that opioid receptors are localized within epithelium of human trachea and large bronchi, a target site for a dosimetric nebulizer. The aim of this study was to compare any clinical or statistical differences in breathlessness intensity between nebulized 2.0% morphine and 0,9% NaCl in patients with very severe COPD. The study was a double-blind, controlled, cross-over trial. Participants received morphine or NaCl during two 4-day periods. Sequence of periods was randomized. The primary outcome measure was reduction of breathlessness intensity now by ≥20 mm using a 100 mm visual analogue scale (VAS) at baseline, 15, 30, 60, 120, 180 and 240 min after daily administration, during normal activities. Ten of 11 patients included completed the study protocol. All patients experienced clinically and statistically significant (p < 0.0001) breathlessness reduction during morphine nebulization. Mean VAS changes for morphine and 0.9% NaCl periods were 25.4 mm (standard deviation (SD): 9.0; median: 23,0; range: 14.0 to 41,5; confidence interval (CI): 95%) and 6.3 mm (SD: 7.8; median: 6.8; range: −11,5 to 19,5; CI: 95%), respectively. No treatment emergent adverse effects were noted. Our study showed superiority of dosimetrically administered nebulized morphine compared to NaCl in reducing breathlessness. This may have been achieved through morphine’s direct action on receptors in large airways, although a systemic effect from absorption through the lungs cannot be excluded. Retrospectively registered (07.03.2017), ISRCTN14865597